Search results
China’s home prices extend fall in April as Beijing steps up revival plans
South China Morning Post· 9 hours agoSales reported by the nation’s top 100 developers tumbled 47 per cent in the first four months, from...
China Bourse May Surrender Support At 3,100 Points
RTT News· 14 hours agoThe China stock market on Thursday snapped the three-day losing streak in which it had slumped almost 35 points or 1.1 percent. The Shanghai Composite Index now sits just ...
Morning Brew: GameStop Announces Share Sale, Faraday Future Surg
Guru Focus· 2 hours agoStock market futures are showing a slight uptick this morning, with S&P 500 futures up by two...
Country Garden buys more time as Hong Kong court adjourns winding-up hearing
South China Morning Post· 13 hours agoA government report on Friday showed home prices extended a slide in April, prompting China to step...
China Shares Poised To End Losing Streak
RTT News· 3 days agoThe China stock market has tracked lower in two straight sessions, slipping almost 10 points or 0.3 percent along the way. The Shanghai Composite Index now sits just above ...
China Stock Market May Find Traction On Thursday
RTT News· 2 days agoThe China stock market has tracked lower in three straight sessions, slipping almost 35 points or 1.1 percent along the way. The Shanghai Composite Index now sits just beneath ...
9 Shenzhen companies included on Fortune ESG list
China Daily· 2 days agoNine Shenzhen enterprises made it onto a list of China's most influential firms in terms of ESG development, according to the latest report by Fortune & ...
Funds Linked to Morgan Stanley, Blue Owl Join Bond Sales Blitz
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- Business development companies, which invest in small and mid-sized firms typically...
China Stock Market May Extend Monday's Losses
RTT News· 4 days agoThe China stock market on Monday snapped the two-day winning streak in which it had gathered more than 25 points or 0.7 percent. The Shanghai Composite Index now sits just ...
Q1 2024 Legend Biotech Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 days agoThese costs are in connection with our agreement with Novartis to develop, manufacture and commercialize LB2102 and other potential CAR-T therapies selectively targeting DL3. Research and < ...
